Sunday, 20 September 2009

Vagifem




In the US, Vagifem (estradiol topical) is a member of the following drug classes: estrogens, miscellaneous vaginal agents and is used to treat Atrophic Urethritis, Atrophic Vaginitis and Hypoestrogenism.

US matches:

  • Vagifem local

UK matches:

  • Vagifem 25 ?g film-coated tablets
  • Vagifem 10 micrograms vaginal tablets (SPC)
  • Vagifem 25 µg film-coated tablets (SPC)

Ingredient matches for Vagifem



Estradiol

Estradiol is reported as an ingredient of Vagifem in the following countries:


  • Austria

  • Bosnia & Herzegowina

  • Canada

  • Denmark

  • Egypt

  • Estonia

  • Ghana

  • Greece

  • Ireland

  • Israel

  • Italy

  • Kenya

  • Latvia

  • Lithuania

  • Luxembourg

  • Netherlands

  • Nigeria

  • Norway

  • Serbia

  • Singapore

  • Slovenia

  • South Africa

  • Sudan

  • Tanzania

  • Uganda

  • United States

  • Zambia

Estradiol hemihydrate (a derivative of Estradiol) is reported as an ingredient of Vagifem in the following countries:


  • Australia

  • Belgium

  • Chile

  • Croatia (Hrvatska)

  • Czech Republic

  • Finland

  • Germany

  • Hong Kong

  • Hungary

  • Iceland

  • Malta

  • New Zealand

  • Poland

  • Portugal

  • Romania

  • Slovakia

  • Spain

  • Sweden

  • Switzerland

  • Turkey

  • United Kingdom

  • United States

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Kenoket




Kenoket may be available in the countries listed below.


Ingredient matches for Kenoket



Clonazepam

Clonazepam is reported as an ingredient of Kenoket in the following countries:


  • Mexico

International Drug Name Search

Saturday, 19 September 2009

romiplostim


Generic Name: romiplostim (ROM i PLOS tim)

Brand Names: Nplate


What is romiplostim?

Romiplostim is a man-made form of a protein that increases production of platelets (blood-clotting cells) in your body.


Romiplostim is used to prevent bleeding episodes in people with chronic immune thrombocytopenic purpura (ITP), a bleeding condition caused by a lack of platelets in the blood.


Romiplostim is usually given after other medications have been tried without successful treatment of symptoms.


Romiplostim is not a cure for ITP and it will not make your platelet counts normal if you have this condition.

Romiplostim may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about romiplostim?


Romiplostim is available only under a special program called Nplate NEXUS. You must be enrolled in this program and sign all required agreements in order to receive the medication. Read all program brochures and agreements carefully.


Romiplostim is not a cure for ITP and it will not make your platelet counts normal if you have this condition.

Before you use romiplostim, tell your doctor if you have kidney or liver disease.


Using romiplostim long-term can cause harmful effects on your bone marrow that may result in serious blood cell disorders. To be sure this medication is helping your condition and not causing harmful effects, your blood will need to be tested often. Do not miss any scheduled visits to your doctor.

It may take up to 4 weeks of using this medicine before it is completely effective in preventing bleeding episodes. Talk with your doctor if you have any bruising or bleeding episodes after 4 weeks of treatment.


After you stop using romiplostim, your risk of bleeding may be even higher than it was before you started treatment. Be extra careful to avoid cuts or injury for at least 2 weeks after you stop using romiplostim. Your blood will need to be tested weekly during this time.

What should I discuss with my health care provider before receiving romiplostim?


If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before you use romiplostim, tell your doctor if you have kidney or liver disease.


FDA pregnancy category C. It is not known whether romiplostim is harmful to an unborn baby. Before you receive this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment.

Your name may need to be listed on a pregnancy registry if you become pregnant while receiving romiplostim. The purpose of this registry is to track the outcome of the pregnancy and delivery to evaluate whether romiplostim had any effect on the baby


It is not known whether romiplostim passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Using romiplostim may increase your risk of developing blood cancers, especially if you have myelodysplastic syndrome (also called "preleukemia"). Talk with your doctor if you have concerns about this risk.


Using romiplostim long-term can cause harmful effects on your bone marrow that may result in serious blood cell disorders. To be sure this medication is helping your condition and not causing harmful effects, your blood will need to be tested often. Do not miss any scheduled visits to your doctor.

How is romiplostim given?


Romiplostim is available only under a special program called Nplate NEXUS. You must be enrolled in this program and sign all required agreements in order to receive the medication. Read all program brochures and agreements carefully.


Romiplostim is given as an injection under the skin, usually once per week. Your doctor, nurse, or other healthcare provider will give you this injection.


It may take up to 4 weeks of using this medicine before it is completely effective in preventing bleeding episodes. For best results, keep receiving the medication as directed. Talk with your doctor if you have any bruising or bleeding episodes after 4 weeks of treatment.


After you stop using romiplostim, your risk of bleeding may be even higher than it was before you started treatment. Be extra careful to avoid cuts or injury for at least 2 weeks after you stop using romiplostim. Your blood will need to be tested weekly during this time.

What happens if I miss a dose?


Call your doctor for instructions if you miss an appointment for your romiplostim injection.


What happens if I overdose?


Seek emergency medical attention if you think you have received too much of this medicine.

Overdose can cause signs of a blood clot, including sudden numbness or weakness, sudden headache or confusion, problems with vision or speech, loss of balance, chest pain, sudden cough, wheezing, rapid breathing, fast heart rate, and pain or swelling in one or both legs.


What should I avoid while receiving romiplostim?


Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are using romiplostim.


Romiplostim side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Less serious side effects may include:



  • headache;




  • dizziness;




  • joint or muscle pain;




  • pain in your arms, legs, or shoulder;




  • numbness or tingly feeling;




  • sleep problems (insomnia); or




  • stomach pain or upset.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


Romiplostim Dosing Information


Usual Adult Dose for Idiopathic (Immune) Thrombocytopenic Purpura:

Initial dose: 1 mcg/kg subcutaneous injection based on actual body weight.

Use the lowest dose of romiplostim to achieve and maintain a platelet count greater than or equal to 50 x 10^9/L as necessary to reduce the risk for bleeding. Administer romiplostim as a weekly subcutaneous injection with dose adjustments based upon the platelet count response. Romiplostim should not be used in an attempt to normalize platelet counts.


What other drugs will affect romiplostim?


There may be other drugs that can interact with romiplostim. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More romiplostim resources


  • Romiplostim Side Effects (in more detail)
  • Romiplostim Use in Pregnancy & Breastfeeding
  • Romiplostim Support Group
  • 1 Review for Romiplostim - Add your own review/rating


  • romiplostim Subcutaneous Advanced Consumer (Micromedex) - Includes Dosage Information

  • Nplate Prescribing Information (FDA)

  • Nplate Consumer Overview

  • Romiplostim Professional Patient Advice (Wolters Kluwer)

  • Romiplostim Monograph (AHFS DI)

  • Romiplostim MedFacts Consumer Leaflet (Wolters Kluwer)



Compare romiplostim with other medications


  • Idiopathic Thrombocytopenic Purpura


Where can I get more information?


  • Your doctor or pharmacist can provide more information about romiplostim.

See also: romiplostim side effects (in more detail)


Friday, 18 September 2009

Rasagiline




In the US, Rasagiline (rasagiline systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease.

US matches:

  • Rasagiline

  • Rasagiline Mesylate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N04BD02

CAS registry number (Chemical Abstracts Service)

0136236-51-6

Chemical Formula

C12-H13-N

Molecular Weight

171

Therapeutic Categories

Treatment of Parkinson's disease

Inhibitor of monoamin oxidase type B (MAO-B)

Chemical Names

(R)-N-2-propynyl-1-indanamine

N-propargyl-1-(R)-aminoindan

Foreign Names

  • Rasagilinum (Latin)
  • Rasagilin (German)
  • Rasagiline (French)
  • Rasagilina (Spanish)

Generic Names

  • Rasagiline mesylate (OS: USAN)
  • AGN-1135 (IS)
  • Rasagiline methanesulfonate (IS)
  • TVP 1012 (IS: Teva)
  • TVP-101 (IS)

Brand Names

  • Azilect
    Teva, Bulgaria; Teva, Russian Federation; Teva, Slovakia; Key Oncologics, South Africa; Lundbeck, Belgium; Lundbeck, Switzerland; Lundbeck, Germany; Lundbeck, Spain; Lundbeck, Finland; Lundbeck, France; Lundbeck, Croatia (Hrvatska); Lundbeck, Ireland; Lundbeck, Italy; Lundbeck, Sweden; Lundbeck, Turkey; Teva, Austria; Teva, Czech Republic; Teva, Germany; Teva, Denmark; Teva, Israel; Teva, Luxembourg; Teva, Netherlands; Teva, Norway; Teva, Slovenia; Teva Neuroscience, Canada; Teva Neuroscience, United States; Teva Pharmaceuticals, United Kingdom


  • Elbrus
    Roemmers, Argentina

International Drug Name Search

Glossary

ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

SalbuSandoz Easyhaler




SalbuSandoz Easyhaler may be available in the countries listed below.


Ingredient matches for SalbuSandoz Easyhaler



Salbutamol

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of SalbuSandoz Easyhaler in the following countries:


  • Germany

International Drug Name Search

Thursday, 17 September 2009

Endorem




Endorem may be available in the countries listed below.


Ingredient matches for Endorem



Ferumoxides

Ferumoxides is reported as an ingredient of Endorem in the following countries:


  • Austria

  • Belgium

  • Denmark

  • France

  • Germany

  • Greece

  • Italy

  • Luxembourg

  • Norway

  • Portugal

  • Spain

  • Sweden

  • Switzerland

  • Turkey

International Drug Name Search

Friday, 4 September 2009

Metotrexato Microsules




Metotrexato Microsules may be available in the countries listed below.


Ingredient matches for Metotrexato Microsules



Methotrexate

Methotrexate sodium salt (a derivative of Methotrexate) is reported as an ingredient of Metotrexato Microsules in the following countries:


  • Argentina

International Drug Name Search

Rifaximin



Pronunciation: rif-AX-i-min
Generic Name: Rifaximin
Brand Name: Xifaxan


Rifaximin is used for:

Decreasing the risk that hepatic encephalopathy (a serious liver problem) will occur again in patients who have already had it. It may be used for other conditions as determined by your doctor.


Rifaximin is an antibiotic. Exactly how it works to treat hepatic encephalopathy is not known. It is thought to have an effect on the bacteria in the stomach.


Do NOT use Rifaximin if:


  • you are allergic to any ingredient in Rifaximin or to a rifamycin antibiotic (eg, rifampin)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Rifaximin:


Some medical conditions may interact with Rifaximin. Tell your health care provider if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have severe diarrhea caused by antibiotics (pseudomembranous colitis) or food poisoning

  • if you have diarrhea with a fever or blood in the stool

  • if you have moderate to severe liver damage

Some MEDICINES MAY INTERACT with Rifaximin. However, no specific interactions with Rifaximin are known at this time.


Ask your health care provider if Rifaximin may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Rifaximin:


Use Rifaximin as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Rifaximin by mouth with or without food.

  • Rifaximin works best if it is taken at the same time each day.

  • Continue to take Rifaximin even if you feel well. Do not miss any doses.

  • If you miss a dose of Rifaximin, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Rifaximin.



Important safety information:


  • Rifaximin may cause dizziness. This effect may be worse if you take it with alcohol or certain medicines. Use Rifaximin with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Mild diarrhea is common with antibiotic use. However, a more serious form of diarrhea (pseudomembranous colitis) may rarely occur. This may develop while you use the antibiotic or within several months after you stop using it. Contact your doctor right away if stomach pain or cramps, severe diarrhea, or bloody stools occur. Do not treat diarrhea without first checking with your doctor.

  • Long-term or repeated use of Rifaximin may cause a second infection. Tell your doctor if signs of a second infection occur. Your medicine may need to be changed to treat this.

  • Be sure to use Rifaximin for the full course of treatment. If you do not, the medicine may not clear up your infection completely. The bacteria could also become less sensitive to this or other medicines. This could make infection harder to treat in the future.

  • Use Rifaximin with extreme caution in CHILDREN younger than 18 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Rifaximin while you are pregnant. It is not known if Rifaximin is found in breast milk. Do not breast-feed while taking Rifaximin.


Possible side effects of Rifaximin:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Dizziness; gas; headache; nausea; tiredness.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty swallowing or breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; flushing; unusual hoarseness); bloody stools; fever; severe diarrhea; severe or persistent tiredness or weakness; shortness of breath; stomach pain or cramping; swelling of the hands, ankles, feet, or stomach.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Rifaximin side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Rifaximin:

Store Rifaximin at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Rifaximin out of the reach of children and away from pets.


General information:


  • If you have any questions about Rifaximin, please talk with your doctor, pharmacist, or other health care provider.

  • Rifaximin is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Rifaximin. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Rifaximin resources


  • Rifaximin Side Effects (in more detail)
  • Rifaximin Use in Pregnancy & Breastfeeding
  • Rifaximin Support Group
  • 14 Reviews for Rifaximin - Add your own review/rating


Compare Rifaximin with other medications


  • Crohn's Disease
  • Diarrhea
  • Hepatic Encephalopathy
  • Irritable Bowel Syndrome
  • Traveler's Diarrhea